GevRx Nutraceuticals, Inc.
New Filing
CIK: 0002156105·Biotechnology·DELAWARE·Filed: Sep 18, 2026
Total Offering
$3,000,000
Amount Sold
$300,000
Investors
1
First Sale
Sep 11, 2026
Offering Details
- Type
- Equity
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Year Incorporated
- 2026
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| James Thomas Christopher | |
| Douglas Spiel, M.D. | |
| Mary Stephen Esposito | |
| Dylan Tyler Spiel | |
| Michael J. Betley, Ph.D. |
Company
SEC Filing
0001213900-26-101304
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free